J. Mercieca

发表

Guidelines for the diagnosis and management of aplastic anaemia

J. Cavenagh, S. Killick, S. Ball, 2009, British journal of haematology.

Guidelines for the diagnosis and management of acquired aplastic anaemia

D. Oscier, S. Ball, E. Gordon-Smith, 2003, British journal of haematology.

Comparison of immunofiltration assay of plasma D‐dimer with diagnostic imaging in deep vein thrombosis

D. Bevan, J. Mercieca, S. Killick, 1997, British journal of haematology.

Eosinophilic fasciitis associated with hypereosinophilia, abnormal bone‐marrow karyotype and inversion of chromosome 5

J. Ferguson, J. Mercieca, C. Holden, 2014, Clinical and experimental dermatology.

Response to Drs Jones and Brodsky

D. Oscier, S. Ball, E. Gordon-Smith, 2004 .

Life‐threatening bowel perforation while on thalidomide‐based triplet regimen for multiple myeloma: a retrospective case series

P. Sriskandarajah, J. Mercieca, F. Scott, 2016, British journal of haematology.

Two new mutations in the HIF2A gene associated with erythrocytosis

M. McMullin, C. Harrison, A. Hoffbrand, 2012, American journal of hematology.

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

A. Pettitt, J. Radford, C. Fegan, 2011, British journal of haematology.

ACUTE HAEMOLYTIC ANAEMIA DUE TO PHENAZOPYRIDINE HYDROCHLORIDE IN G-6-PD DEFICIENT SUBJECT

M. Phillips, J. Mercieca, J. Curtis, 1982, The Lancet.

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

D. Catovsky, E. Matutes, M. Dyer, 1997, Leukemia.

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

G. Morgan, F. Davies, K. Boyd, 2012, British journal of haematology.